dr. reddy's labs glp-1 receptor agonists weight management diabetes treatments cardinal health agonist GLP-1 Agonists: Revolutionizing the Treatment of Obesity, but Are They Enough? - Eric Velazquez, MD - Bariatric Surgeon dr. reddy's labs glp-1 receptor
Description
WEDNESDAY, June 10, 2026 (HealthDay News) -- Continuation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) into early pregnancy seems not to be associat
Quality Standards & Traceability
An increasing number of patients treated with novel antidiabetic drugs, including glucagon-like-peptide-1 receptor agonists (GLP-1RA), dual glucose-dependent insulinotropic polypeptide receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors, are presenting in the perioperative...
Gastrointestinal side effects are a little more common in the oral version than in the injectables
Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year.
No direct causal link has been established between GLP-1R use and increased aspiration risk
